Global Biologics & Biosimilars Sales Market Report 2018

June 2018 | 112 pages | ID: GCD3843C4BFEN
QYResearch

Abstracts

This report studies the global Biologics & Biosimilars market status and forecast, categorizes the global Biologics & Biosimilars market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Biologics & Biosimilars market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report

• fizer
• Roche
• Amgen
• AbbVie
• Sanofi
• Johnson & Johnson
• Novo Nordisk
• Novartis
• Merck
• Lilly
• 3sbio
• Changchun High Tech
• CP Guojian Pharmacy
• Biotech Pharma
• Gelgen Biopharma
• Sandoz
• Teva
• Hospira
• Mylan

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antibiotic
• Enzyme
• Hormone
• Non-Patented Biological Reagents
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Other

The study objectives of this report are:

• To analyze and study the global Biologics & Biosimilars sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Biologics & Biosimilars players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologics & Biosimilars are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Biologics & Biosimilars Manufacturers
Biologics & Biosimilars Distributors/Traders/Wholesalers
Biologics & Biosimilars Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biologics & Biosimilars market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Biologics & Biosimilars Sales Market Report 2018

1 BIOLOGICS & BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologics & Biosimilars
1.2 Classification of Biologics & Biosimilars by Product Category
  1.2.1 Global Biologics & Biosimilars Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Biologics & Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Antibiotic
  1.2.4 Enzyme
  1.2.5 Hormone
  1.2.6 Non-Patented Biological Reagents
  1.2.7 Other
1.3 Global Biologics & Biosimilars Market by Application/End Users
  1.3.1 Global Biologics & Biosimilars Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Tumor
  1.3.2 Diabetes
  1.3.3 Cardiovascular
  1.3.4 Hemophilia
  1.3.5 Other
1.4 Global Biologics & Biosimilars Market by Region
  1.4.1 Global Biologics & Biosimilars Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.3 Europe Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.4 China Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.5 Japan Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.7 India Biologics & Biosimilars Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Biologics & Biosimilars (2013-2025)
  1.5.1 Global Biologics & Biosimilars Sales and Growth Rate (2013-2025)
  1.5.2 Global Biologics & Biosimilars Revenue and Growth Rate (2013-2025)

2 GLOBAL BIOLOGICS & BIOSIMILARS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Biologics & Biosimilars Market Competition by Players/Suppliers
  2.1.1 Global Biologics & Biosimilars Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Biologics & Biosimilars Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Biologics & Biosimilars (Volume and Value) by Type
  2.2.1 Global Biologics & Biosimilars Sales and Market Share by Type (2013-2018)
  2.2.2 Global Biologics & Biosimilars Revenue and Market Share by Type (2013-2018)
2.3 Global Biologics & Biosimilars (Volume and Value) by Region
  2.3.1 Global Biologics & Biosimilars Sales and Market Share by Region (2013-2018)
  2.3.2 Global Biologics & Biosimilars Revenue and Market Share by Region (2013-2018)
2.4 Global Biologics & Biosimilars (Volume) by Application

3 UNITED STATES BIOLOGICS & BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Biologics & Biosimilars Sales and Value (2013-2018)
  3.1.1 United States Biologics & Biosimilars Sales and Growth Rate (2013-2018)
  3.1.2 United States Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
  3.1.3 United States Biologics & Biosimilars Sales Price Trend (2013-2018)
3.2 United States Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
3.3 United States Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
3.4 United States Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

4 EUROPE BIOLOGICS & BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Biologics & Biosimilars Sales and Value (2013-2018)
  4.1.1 Europe Biologics & Biosimilars Sales and Growth Rate (2013-2018)
  4.1.2 Europe Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Biologics & Biosimilars Sales Price Trend (2013-2018)
4.2 Europe Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

5 CHINA BIOLOGICS & BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 China Biologics & Biosimilars Sales and Value (2013-2018)
  5.1.1 China Biologics & Biosimilars Sales and Growth Rate (2013-2018)
  5.1.2 China Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
  5.1.3 China Biologics & Biosimilars Sales Price Trend (2013-2018)
5.2 China Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
5.3 China Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
5.4 China Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

6 JAPAN BIOLOGICS & BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biologics & Biosimilars Sales and Value (2013-2018)
  6.1.1 Japan Biologics & Biosimilars Sales and Growth Rate (2013-2018)
  6.1.2 Japan Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Biologics & Biosimilars Sales Price Trend (2013-2018)
6.2 Japan Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA BIOLOGICS & BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Biologics & Biosimilars Sales and Value (2013-2018)
  7.1.1 Southeast Asia Biologics & Biosimilars Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Biologics & Biosimilars Sales Price Trend (2013-2018)
7.2 Southeast Asia Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

8 INDIA BIOLOGICS & BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 India Biologics & Biosimilars Sales and Value (2013-2018)
  8.1.1 India Biologics & Biosimilars Sales and Growth Rate (2013-2018)
  8.1.2 India Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
  8.1.3 India Biologics & Biosimilars Sales Price Trend (2013-2018)
8.2 India Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
8.3 India Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
8.4 India Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL BIOLOGICS & BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 fizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biologics & Biosimilars Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 fizer Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Roche
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Biologics & Biosimilars Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Roche Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Amgen
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Biologics & Biosimilars Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Amgen Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 AbbVie
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Biologics & Biosimilars Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 AbbVie Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Sanofi
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Biologics & Biosimilars Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Sanofi Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Johnson & Johnson
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Biologics & Biosimilars Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Johnson & Johnson Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Biologics & Biosimilars Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Novo Nordisk Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Novartis
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Biologics & Biosimilars Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Novartis Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Merck
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Biologics & Biosimilars Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Merck Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Lilly
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Biologics & Biosimilars Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Lilly Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 3sbio
9.12 Changchun High Tech
9.13 CP Guojian Pharmacy
9.14 Biotech Pharma
9.15 Gelgen Biopharma
9.16 Sandoz
9.17 Teva
9.18 Hospira
9.19 Mylan

10 BIOLOGICS & BIOSIMILARS MAUFACTURING COST ANALYSIS

10.1 Biologics & Biosimilars Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biologics & Biosimilars
10.3 Manufacturing Process Analysis of Biologics & Biosimilars

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biologics & Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologics & Biosimilars Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOLOGICS & BIOSIMILARS MARKET FORECAST (2018-2025)

14.1 Global Biologics & Biosimilars Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Biologics & Biosimilars Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Biologics & Biosimilars Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Biologics & Biosimilars Price and Trend Forecast (2018-2025)
14.2 Global Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Biologics & Biosimilars Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Biologics & Biosimilars Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Biologics & Biosimilars Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Biologics & Biosimilars Sales Forecast by Type (2018-2025)
  14.3.2 Global Biologics & Biosimilars Revenue Forecast by Type (2018-2025)
  14.3.3 Global Biologics & Biosimilars Price Forecast by Type (2018-2025)
14.4 Global Biologics & Biosimilars Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biologics & Biosimilars
Figure Global Biologics & Biosimilars Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Biologics & Biosimilars Sales Volume Market Share by Type (Product Category) in 2017
Figure Antibiotic Product Picture
Figure Enzyme Product Picture
Figure Hormone Product Picture
Figure Non-Patented Biological Reagents Product Picture
Figure Other Product Picture
Figure Global Biologics & Biosimilars Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Biologics & Biosimilars by Application in 2017
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Biologics & Biosimilars Market Size (Million USD) by Regions (2013-2025)
Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Biologics & Biosimilars Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Biologics & Biosimilars Sales Volume (K Units) (2013-2018)
Table Global Biologics & Biosimilars Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Biologics & Biosimilars Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Biologics & Biosimilars Sales Share by Players/Suppliers
Figure 2017 Biologics & Biosimilars Sales Share by Players/Suppliers
Figure Global Biologics & Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biologics & Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biologics & Biosimilars Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Biologics & Biosimilars Revenue Share by Players
Table 2017 Global Biologics & Biosimilars Revenue Share by Players
Table Global Biologics & Biosimilars Sales (K Units) and Market Share by Type (2013-2018)
Table Global Biologics & Biosimilars Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Biologics & Biosimilars by Type (2013-2018)
Figure Global Biologics & Biosimilars Sales Growth Rate by Type (2013-2018)
Table Global Biologics & Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Biologics & Biosimilars Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biologics & Biosimilars by Type (2013-2018)
Figure Global Biologics & Biosimilars Revenue Growth Rate by Type (2013-2018)
Table Global Biologics & Biosimilars Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Biologics & Biosimilars Sales Share by Region (2013-2018)
Figure Sales Market Share of Biologics & Biosimilars by Region (2013-2018)
Figure Global Biologics & Biosimilars Sales Growth Rate by Region in 2017
Table Global Biologics & Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biologics & Biosimilars Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biologics & Biosimilars by Region (2013-2018)
Figure Global Biologics & Biosimilars Revenue Growth Rate by Region in 2017
Table Global Biologics & Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biologics & Biosimilars Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biologics & Biosimilars by Region (2013-2018)
Figure Global Biologics & Biosimilars Revenue Market Share by Region in 2017
Table Global Biologics & Biosimilars Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Biologics & Biosimilars Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Biologics & Biosimilars by Application (2013-2018)
Figure Global Biologics & Biosimilars Sales Market Share by Application (2013-2018)
Figure United States Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table United States Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
Table United States Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
Figure United States Biologics & Biosimilars Sales Volume Market Share by Players in 2017
Table United States Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table United States Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure United States Biologics & Biosimilars Sales Volume Market Share by Type in 2017
Table United States Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
Table United States Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure United States Biologics & Biosimilars Sales Volume Market Share by Application in 2017
Figure Europe Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
Table Europe Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
Figure Europe Biologics & Biosimilars Sales Volume Market Share by Players in 2017
Table Europe Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table Europe Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Europe Biologics & Biosimilars Sales Volume Market Share by Type in 2017
Table Europe Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
Table Europe Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Europe Biologics & Biosimilars Sales Volume Market Share by Application in 2017
Figure China Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table China Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
Table China Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
Figure China Biologics & Biosimilars Sales Volume Market Share by Players in 2017
Table China Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table China Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure China Biologics & Biosimilars Sales Volume Market Share by Type in 2017
Table China Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
Table China Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure China Biologics & Biosimilars Sales Volume Market Share by Application in 2017
Figure Japan Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
Table Japan Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
Figure Japan Biologics & Biosimilars Sales Volume Market Share by Players in 2017
Table Japan Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table Japan Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Japan Biologics & Biosimilars Sales Volume Market Share by Type in 2017
Table Japan Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
Table Japan Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Japan Biologics & Biosimilars Sales Volume Market Share by Application in 2017
Figure Southeast Asia Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Players in 2017
Table Southeast Asia Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Type in 2017
Table Southeast Asia Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Application in 2017
Figure India Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
Figure India Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
Table India Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
Table India Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
Figure India Biologics & Biosimilars Sales Volume Market Share by Players in 2017
Table India Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
Table India Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
Figure India Biologics & Biosimilars Sales Volume Market Share by Type in 2017
Table India Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
Table India Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
Figure India Biologics & Biosimilars Sales Volume Market Share by Application in 2017
Table fizer Basic Information List
Table fizer Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure fizer Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure fizer Biologics & Biosimilars Sales Global Market Share (2013-2018)
Figure fizer Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Roche Biologics & Biosimilars Sales Global Market Share (2013-2018)
Figure Roche Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Amgen Biologics & Biosimilars Sales Global Market Share (2013-2018
Figure Amgen Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure AbbVie Biologics & Biosimilars Sales Global Market Share (2013-2018)
Figure AbbVie Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Sanofi Biologics & Biosimilars Sales Global Market Share (2013-2018)
Figure Sanofi Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Sales Global Market Share (2013-2018
Figure Johnson & Johnson Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Sales Global Market Share (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Novartis Biologics & Biosimilars Sales Global Market Share (2013-2018
Figure Novartis Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Merck Basic Information List
Table Merck Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Merck Biologics & Biosimilars Sales Global Market Share (2013-2018)
Figure Merck Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table Lilly Basic Information List
Table Lilly Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lilly Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Lilly Biologics & Biosimilars Sales Global Market Share (2013-2018)
Figure Lilly Biologics & Biosimilars Revenue Global Market Share (2013-2018)
Table 3sbio Basic Information List
Table Changchun High Tech Basic Information List
Table CP Guojian Pharmacy Basic Information List
Table Biotech Pharma Basic Information List
Table Gelgen Biopharma Basic Information List
Table Sandoz Basic Information List
Table Teva Basic Information List
Table Hospira Basic Information List
Table Mylan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics & Biosimilars
Figure Manufacturing Process Analysis of Biologics & Biosimilars
Figure Biologics & Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics & Biosimilars Major Players in 2017
Table Major Buyers of Biologics & Biosimilars
Table Distributors/Traders List
Figure Global Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Biologics & Biosimilars Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Biologics & Biosimilars Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Biologics & Biosimilars Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Biologics & Biosimilars Sales Volume Market Share Forecast by Regions in 2025
Table Global Biologics & Biosimilars Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Biologics & Biosimilars Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Biologics & Biosimilars Revenue Market Share Forecast by Regions in 2025
Figure United States Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Biologics & Biosimilars Revenue and Growth Rate Forecast (2018-2025)
Figure China Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Biologics & Biosimilars Sales (K Units) Forecast by Type (2018-2025)
Figure Global Biologics & Biosimilars Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Biologics & Biosimilars Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Biologics & Biosimilars Revenue Market Share Forecast by Type (2018-2025)
Table Global Biologics & Biosimilars Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Biologics & Biosimilars Sales (K Units) Forecast by Application (2018-2025)
Figure Global Biologics & Biosimilars Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources